Patent details

EP3656443 Title: USE OF TRL AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS

Basic Information

Publication number:
EP3656443
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP191974856
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF TRL AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS
French Title of Invention:
UTILISATION D'AGONISTE DE TLR ET D'AGENT ANTI-CD47 POUR STIMULER LA PHAGOCYTOSE DES CELLULES CANCÉREUSES
German Title of Invention:
VERWENDUNG VON TLR AGONISTEN UND ANTI-CD47 MITTELN ZUR STIMULIERUNG DER PHAGOZYTOSE VON KREBSZELLEN
SPC Number:

Dates

Filing date:
21/01/2016
Grant date:
29/09/2021
EP Publication Date:
27/05/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/09/2021
EP B1 Publication Date:
29/09/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/01/2022
Expiration date:
21/01/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/09/2021
 
 

Name:
The Board of Trustees of the Leland Stanford Junior University
Address:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, United States (US)

Inventor

1

Name:
WEISSMAN, Irving L.
Address:
United States (US)

2

Name:
FENG, Mingye
Address:
United States (US)

3

Name:
VOLKMER, Jens-Peter
Address:
United States (US)

Priority

Priority Number:
201562106050 P
Priority Date:
21/01/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/39; A61K 39/395; A61K 45/06; A61K 31/4745; A61K 31/713; A61K 35/15; A61P 7/00; A61P 35/00; C07K 16/18; C07K 16/28; A61K 31/519;

Publication

European Patent Bulletin

1

Issue number:
202139
Publication date:
29/09/2021
Description:
Grant (B1)

2

Issue number:
202144
Publication date:
03/11/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202231
Publication date:
03/08/2022
Description:
Opposition procedure started

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages